Claire Keating, M.D.

Associate Professor of Medicine at Columbia University Medical Center
Associate Director, Gunnar Esaison Adult Cystic Fibrosis and Lung Center

Bio

Claire Keating, MD is the Associate Director of the Gunnar Esiason Adult Cystic Fibrosis and Lung Program since 2009. She has done epidemiologic research in adult-diagnosis cystic fibrosis and has presented posters and published several abstracts and a paper. She is currently serving as PI on two pharmaceutical trials in cystic fibrosis and is a sub-investigator on several other clinical trials in pulmonary diseases.

Education and Training

Undergraduate:
B.S. with Honors, Biological Sciences: Genetics and Development, Cornell University, Ithaca, NY, 1997
Medical School:
Tufts University Medical School, 2003
Internship:
NewYork-Presbyterian Hospital, Weill Cornell Medical Center, 2004
Residency:
NewYork-Presbyterian Hospital, Weill Cornell Medical Center, 2006
Fellowship(s):
Clinical Fellow Pulmonary and Critical Care Medicine, NewYork-Presbyterian/Columbia University Medical Center, 2006-2009

Honors and Awards

2019-2021
Therapeutic Development Network Principal Investigator Protected Effort (PIPE) Award
2015
Cystic Fibrosis Foundation
OneCF Learning and Leadership Collaborative 2, Quality Improvement Award - Team Leader
2013
Cystic Fibrosis Foundation
Adult Quality Improvement 3, Learning and Leadership Collaborative Quality Improvement Award - Team Leader
2006
Weill Cornell Medical Center
Daniel M. Libby Program Director’s Award for Clinical Excellence
2001
Tufts University Medical Center
Presidential Award for Citizenship and Public Service
1997
Cornell University
Golden Key National Honor Society, Cornell University

Clinical

For appointments: 

Adult CF Center
622 W. 168th Street
PH 8-Center
New York, NY 10032
P: (212) 305-0631
F: (212) 342-4784

Columbia Pulmonary Associates
Herbert Irving Pavilion
161 Fort Washington Avenue, 310
New York, NY 10032
P: (212) 305-1544
F: (212) 342-1882

Specialties

  • Pulmonary Disease Medicine

Clinical Expertise

  • General Pulmonary Medicine
  • Cystic Fibrosis
  • Bronchiectasis

Clinical Centers

Board Certifications

  • Internal Medicine Diplomate, 2006
  • Pulmonary Disease Diplomate, 2008

Research

Research Interests

  • Non-cystic fibrosis bronchiectasis
  • Adult diagnosis of cystic fibrosis
  • Cystic fibrosis therapeutics

Selected Publications

  1. Djavid AR, Thompson AE, Irace AL, Gusman E, Altman K, DiMango EA, Keating CL. Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Advanced Cystic Fibrosis Lung Disease. Ann Am Thorac Soc. 2021 May 17
  2. DiMango E, Overdevest J, Keating C, Francis SF, Dansky D, Gudis D. Effect of highly effective modulator treatment on sinonasal symptoms in cystic fibrosis. J Cyst Fibros. 2021 May;20(3):460-463.
  3. Emily DiMango; Kaitlyn Simpson; Elizabeth Menten; Claire Keating; Weijia Fan; Cheng-Shiun Leu. Health Disparities among adults cared for at an urban cystic fibrosis program. Orphanet J Rare Dis (2021) 16:332
  4. Lucas G Axiotakis Jr; Necati Enver; Claire L Keating; Michael J Pitman. Laryngeal Injury due to Amikacin Inhalation for Refractory MAC Infection. Chest. 2021 Apr;159(4):e185-e187
  5. DiMango E, Overdevest J, Keating C, Francis SF, Dansky D, Gudis D. Effect of highly effective modulator therapy on quality of life in adults with cystic fibrosis Int Forum Allergy Rhinol. 2021 Jan;11(1):75-78.
  6. C.L Keating, J.B. Zuckerman, P.K. Sing3, M. McKevitt, O. Gurtovaya, M. Bresnik, B. Marshall, L. Saiman. Pseudomonas aeruginosa Susceptibility Patterns and Associated Clinical Outcomes in People with Cystic Fibrosis following Approval of Aztreonam Lysine for Inhalation. Antimicrob Agents Chemother. 2021 Feb 17;65(3):e02327-20.
  7. Chetan Safi, Zhong Zheng, Emily Dimango, Claire Keating, David A. Gudis. Chronic Rhinosinusitis in Cystic Fibrosis: Diagnosis and Medical Management. Med. Sci. 2019, 7, 32.
  8. C.L. Keating, J.B. Zuckerman, P.K. Singh, M. McKevitt, O. Gurtovaya, M. Bresnik, B. Marshall, L. Saiman. Are changes in aztreonam susceptibility associated with inhaled aztreonam exposure? Results of a prospective 5-year study of Pseudomonas aeruginosa (PA) isolated from CF patients in the United States. Poster presentation, North American Cystic Fibrosis Conference, Denver, Colorado 2018
  9. C.L Keating, J.B. Zuckerman, P.K. Sing3, M. McKevitt, O. Gurtovaya, M. Bresnik, B. Marshall, L. Saiman. Is there an association of clinical outcomes with changes in aztreonam susceptibility? Results from a prospective 5-year registry study of CF patients in the United States. Thematic poster session, North American Cystic Fibrosis Conference, Denver, Colorado 2018.
  10. Nishiyama KK, Agarwal S, Kepley A, Rosete F, Hu Y, Guo XE, Keating CL, DiMango EA, Shane E. Adults with cystic fibrosis have deficits in bone structure and strength at the distal tibia despite similar size and measuring standard and relative sites. Bone. 2018 Feb;107:181-187
  11. Keating, C, Poor A, Liu X, Chiuzan, C, Backenroth D, Zhang, Y, Dimango E. Reduced survival in adult cystic fibrosis despite attenuated lung function decline. Journal of Cystic Fibrosis. 2017 Jan;16(1):78-84
  12. Keating C, Poor A, Liu X, Dimango E. Delayed diagnosis of cystic fibrosis have slower FEV1 decline but higher risk of death or transplant over time. Workshop Presentation, North American Cystic Fibrosis Conference, Atlanta, GA 2014.
  13. Dimango E, Walker P, Keating C, Berdella M, Robinson N, Langfelder-Schwind E, et al. Effect of esomeprazole versus placebo on pulmonary exacerbations in cystic fibrosis. BMC Pulm Med. 2014 Feb 15;14:21.
  14. Keating CL, Liu X, Dimango EA Classic respiratory disease but atypical diagnostic testing distinguishes adult presentation of cystic fibrosis. Chest. 2010 May;137(5):1157-63.
  15. Keating, C. L., D'Souza, B. M., Mason, D. M., Shu, C. A.; DiMango, E. A., Austin, J. H.M. Adult-Diagnosis of CF – Does it Differ at CT Scan from the Pediatric Population? Poster presentation, North American Cystic Fibrosis Conference, Minneapolis, MN 2009.
  16. Keating C, Liu X, DiMango E. Predictors of Lung Function in Cystic Fibrosis at Diagnosis. Poster Discussion Session, American Thoracic Society Annual Meeting, San Diego, CA 2009.
     

View Dr. Keating's full list of publications from PubMed